Issue of Equity - Replacement

RNS Number : 6694F
Odyssean Investment Trust PLC
22 March 2022
 

22 March 2022

 

The following amendments have been made to the 'Issue of Equity' announcement released on 22 March 2022 at 16.58 under RNS No 6595F.

 

The total number of ordinary shares in issue should have been stated as 96,173,053 and not 96,173,553 and the total number of voting rights in the Company should have been stated as 96,173,053 and not 96,173,553.

 

All other details remain unchanged.

 

The full amended text is shown below .

 

 

ODYSSEAN INVESTMENT TRUST PLC

 

 

 

Issue of Ordinary Shares

 

 

On 22 March 2022 Odyssean Investment Trust plc (the "Company") issued from its blocklisting of 20 June 2018 87,500 new ordinary shares of 1p each at a price of 161.00 pence per share, pursuant to the Company's premium management strategy. These shares rank pari passu with the existing ordinary shares in issue and they were issued at a premium to the estimated net asset value per share at the time of the transaction.

 

The Company has issued 64,000 ordinary shares under its blocklisting facility of 20 June 2018 and a further 23,500 ordinary shares under its blocklisting facility of 25 January 2022. Following this issue, the Company has the ability to issue a further 4,976,500 ordinary shares under its blocklisting facility of 25 January 2022.

 

As a result of this issuance, the total number of ordinary shares in issue is 96,173,053 and the total number of voting rights in the Company is 96,173,053. There are no shares held in treasury.  

 

The above figure may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Kerstin Rucht 

On behalf of Frostrow Capital LLP,

Company Secretary to Odyssean Investment Trust plc 

Tel: 0203 709 8732

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUBUWUPPGRP
UK 100

Latest directors dealings